The applications should be sent to [email protected] by April 6, 2015.

An open letter requests that The Union take steps to retire the use of stigmatizing and criminalizing terminology from the papers published in its journals and the abstracts submitted to its conferences.

The Joint Partners Forum for strengthening and aligning TB diagnosis and treatment, which will unite GLI and GDI partners, will be convened at World Health Organization Headquarters, Geneva, Switzerland on April 27-30, 2015.

This case study documents the experience of a pilot study to implement Xpert®MTB/Rif to replace sputum smear microscopy to diagnose pulmonary tuberculosis in Brazil's Unified Health System in two municipalities.

The meeting will pull together researchers, public health workers, and activists to define an implementation and research agenda for drug-resistant TB and HIV treatment adherence that is centered on the unique needs of the communities most affected by these synergistic epidemics.

More than 45 civil society organisations co-submitted a letter to the new EU Commissioner for Health and Food Safety to use his role to champion the need for an improved response to the multidrug-resistant tuberculosis (MDR-TB) epidemic in the European region.

Ahead of the 1st Eastern Partnership Ministerial Conference on Tuberculosis (TB) and Multidrug Resistant Tuberculosis due to be held in Riga, Latvia on March 30-31, 2015 Médecins Sans Frontières (MSF) shares their experience and recommedations on how to address the deadly gaps in fighting TB.

The past decade has shown what is possible when we work together. We want to make this year a memorable one for TB and we want patients and communities to speak up and be at the core of our efforts this year.

Re: Inclusion of pediatric-specific targets in the Global Plan to Stop TB, 2016-2020

SIGN ON LETTER to global actors and drug companies: Please provide organizational sign-ons by 6 March.